BackgroundCheck.run
Search For

Han H Li, 611 Claire Dr, Upper Makefield, PA 18940

Han Li Phones & Addresses

1 Claire Dr, Newtown, PA 18940    215-3639026   

West Palm Beach, FL   

Las Vegas, NV   

388 Twig Ln, Morrisville, PA 19067    215-3690262    215-3695328    215-7410282   

21102 Cornerstone Dr, Yardley, PA 19067    215-7410282   

Lawrenceville, GA   

Westminster, CO   

Fort Collins, CO   

Rochester, NY   

Mentions for Han H Li

Career records & work history

Lawyers & Attorneys

Han Li Photo 1

Han Li - Lawyer

Office:
Li Thomas & Yu
ISLN:
919754698
Admitted:
1984
Han Li Photo 2

Han Li - Lawyer

ISLN:
922867538
Admitted:
2008
University:
Fordham Law School
Han Li Photo 3

Han Li - Lawyer

ISLN:
1000824912
Admitted:
2018

Medicine Doctors

Han Li Photo 4

Han Li

Specialties:
Surgery

Han Li resumes & CV records

Resumes

Han Li Photo 46

Associate Director

Location:
Newtown, PA
Work:
Bms
Associate Director
Han Li Photo 47

Han Li

Han Li Photo 48

Han Li

Han Li Photo 49

Han Li

Han Li Photo 50

Han Li

Location:
United States
Han Li Photo 51

Documentary Director

Position:
Director at Science and Education Programming Center of CCTV
Location:
Beijing City, China
Industry:
Media Production
Work:
Science and Education Programming Center of CCTV - Beijing, China since Feb 2012
Director
Education:
Ohio University 2009 - 2011
Master of Arts (M.A.), Media Arts and Studies
Rowan University 2006 - 2007
China University of Mining and Technology 2004 - 2008
Bachelor of Arts (B.A.), Broadcasting Journalism
Languages:
English
Chinese
Han Li Photo 52

Han Li

Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals
Han Li Photo 53

Han Li

Location:
United States

Publications & IP owners

Us Patents

Methods For Treatment Of Renal Cell Carcinoma

US Patent:
6538029, Mar 25, 2003
Filed:
May 29, 2002
Appl. No.:
10/157526
Inventors:
W. Joseph Thompson - Doylestown PA
John R. Fetter - North Wales PA
Robert E. Bellet - Elkins Park PA
Han Li - Yardley PA
Assignee:
Cell Pathways - Horsham PA
International Classification:
A61K 3119
US Classification:
514569, 5142312, 514256, 514277, 514365, 514372, 514381, 514482, 514506, 514520, 514553, 514617, 514618, 514619, 514622
Abstract:
A method of treating renal cell carcinoma in a mammal with that disease comprising administering to the mammal a physiologically effective amount of an inhibitor of PDE10.

Method For Screening Compounds For The Treatment Of Neoplasia

US Patent:
6569638, May 27, 2003
Filed:
Mar 3, 2000
Appl. No.:
09/517734
Inventors:
I. Bernard Weinstein - Englewood NJ
W. Joseph Thompson - Doylestown PA
Jae-Won Soh - Cliffside Park NJ
Li Liu - Ambler PA
Han Li - Yardley PA
Assignee:
Cell Pathways, Inc - Horsham PA
International Classification:
C12Q 148
US Classification:
435 15, 435 692, 435184
Abstract:
This invention provides a method to identify compounds potentially useful for the treatment and prevention of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with its ability to elevate JNK kinase activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibition, an ability to elevate JNK kinase activity, growth inhibition and apoptosis induction are desirable for the treatment of neoplasia.

Methods For Identifying Compounds For Inhibition Of Neoplastic Lesions, And Pharmaceutical Compositions Containing Such Compounds

US Patent:
2002000, Jan 24, 2002
Filed:
Oct 8, 1999
Appl. No.:
09/414628
Inventors:
W. JOSEPH THOMPSON - DOYLESTOWN PA, US
LI LIU - AMBLER PA, US
HAN LI - YARDLEY PA, US
International Classification:
C12Q001/44
US Classification:
435/019000
Abstract:
This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The increase in PKG activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit increase PKG activity, growth inhibition and apoptosis induction, but preferably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Method For Diagnosing Neoplasia

US Patent:
2003004, Mar 6, 2003
Filed:
Apr 22, 2002
Appl. No.:
10/125823
Inventors:
Li Liu - North Wales PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Gary Piazza - Doylestown PA, US
Rifat Pamukcu - Spring House PA, US
International Classification:
G01N033/574
G01N001/30
G01N033/48
US Classification:
435/007230, 435/040500
Abstract:
This invention provides a method for diagnosing a patient with neoplasia.

Methods For Identifying Compounds For Inhibition Of Neoplastic Lesions, And Pharmaceutical Compositions Containing Such Compounds

US Patent:
2003010, Jun 12, 2003
Filed:
Jul 2, 2002
Appl. No.:
10/187762
Inventors:
W. Thompson - Doylestown PA, US
Li Liu - Ambler PA, US
Han Li - Yardley PA, US
International Classification:
A61K031/00
C12Q001/42
C12Q001/26
US Classification:
514/001000, 435/025000, 435/021000
Abstract:
This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The increase in PKG activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit increase PKG activity, growth inhibition and apoptosis induction, but preferably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Packaged Pharmaceuticals And Methods For Causing Compounds And Pharmaceutical Compositions To Be Used As Inhibitors Of Neoplastic Lesions

US Patent:
2003017, Sep 18, 2003
Filed:
Sep 20, 2002
Appl. No.:
10/251165
Inventors:
Li Liu - Ambler PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Rifat Pamukcu - Spring House PA, US
Gary Piazza - Doylestown PA, US
International Classification:
A61K031/00
G06F017/60
G01N033/574
US Classification:
435/007230, 514/001000, 705/003000
Abstract:
This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but prefereably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Methods For Treatment Of Diseases Where Gsk 3-Beta Is Desired, And Methods To Identify Compounds Usefule For That

US Patent:
2003019, Oct 16, 2003
Filed:
Apr 5, 2002
Appl. No.:
10/117255
Inventors:
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
International Classification:
A61K031/00
G01N033/53
G01N033/567
C12Q001/48
US Classification:
435/007200, 435/015000, 514/001000
Abstract:
A method for selecting compounds for the treatment of diseases where GSK3 is desired includes assessing whether the compounds cause an increase in PKG activity in the tissue of interest.

Methods For Identifying Compounds For Inhibition Of Neoplastic Lesions, And Pharmacetical Compositions Containing Such Compounds

US Patent:
2004000, Jan 15, 2004
Filed:
Sep 24, 2002
Appl. No.:
10/253629
Inventors:
Li Liu - Ambler PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Rifat Pamukcu - Springhouse PA, US
Gary Piazza - Doylestown PA, US
International Classification:
C12Q001/00
A61K031/60
A61K031/415
US Classification:
435/004000, 514/165000, 514/406000
Abstract:
This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but prefereably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Isbn (Books And Publications)

Meng Ch'Iu: Famous Episodes From Chinese History And Legend

Author:
Han Li
ISBN #:
0870112783

The Water Lily Pond: A Village Girls Journey In Maoist China

Author:
Han Z. Li
ISBN #:
0889204314

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.